KA
Kritika Aggarwal
About Kritika Aggarwal
Data last updated:
Kritika Aggarwal is a Director at Efpia Medicine Private Limited (since 2024) and Director at Wonne International Private Limited (since 2024). The companies operate in Pharma. The largest current company by reported revenue is Efpia Medicine Private Limited at ₹3.08 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Efpia Medicine Private Limited U47721HR2024PTC121120 | Director | 28 Apr 2024 | 2024 | ₹3.08 Cr (FY 2025) | Active |
| Wonne International Private Limited U47721HR2024PTC121268 | Director | 03 May 2024 | 2024 | Active |
Board colleagues of Kritika Aggarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nikhil Aggarwal | 10399480 | Efpia Medicine Private Limited , Wonne International Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kritika Aggarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kritika Aggarwal
Kritika Aggarwal currently holds 2 directorships: Efpia Medicine Private Limited (Director, since 28 Apr 2024, revenue ₹3.08 Cr (FY 2025)); Wonne International Private Limited (Director, since 03 May 2024).
Kritika Aggarwal was first appointed on 28 Apr 2024 as Director at Efpia Medicine Private Limited.
The current boards of Kritika Aggarwal's companies include Nikhil Aggarwal (Efpia Medicine Private Limited).